天智航股价涨5.46%,华夏基金旗下1只基金位居十大流通股东,持有872.38万股浮盈赚取854.93万元

Group 1 - Tianzhihang Medical Technology Co., Ltd. focuses on the research, production, sales, and service of orthopedic surgical navigation robots, with a revenue composition of 58.31% from navigation robots, 23.86% from supporting equipment and consumables, 16.49% from technical services, and 1.31% from other sources [1] - As of January 12, Tianzhihang's stock price increased by 5.46% to 18.94 CNY per share, with a total market capitalization of 8.636 billion CNY and a trading volume of 9.9702 million CNY [1] Group 2 - Huaxia Fund's Huaxia CSI Robot ETF (562500) increased its holdings in Tianzhihang by 1.6284 million shares in the third quarter, bringing its total holdings to 8.7238 million shares, which represents 1.93% of the circulating shares [2] - The Huaxia CSI Robot ETF has a total asset size of 22.798 billion CNY and has achieved a year-to-date return of 4.35%, ranking 2512 out of 5579 in its category [2] Group 3 - The fund manager of Huaxia CSI Robot ETF is Hualong, who has been in the position for 3 years and 145 days, with the fund's total asset size at 35.957 billion CNY and a best return of 139.26% during the tenure [3]

TINAVI-天智航股价涨5.46%,华夏基金旗下1只基金位居十大流通股东,持有872.38万股浮盈赚取854.93万元 - Reportify